01

SPI Pharma

U.S.A

DCAT Week

Attending

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Granule / Pellet, Tablet

Grade : Oral

Brand Name : Mannogem Powder

Application : Fillers, Diluents & Binders, Granulation, Solubilizers

Excipient Details : Mannogem (mannitol powder) is an excellent excipient for use in wet granulation, lyophilization & improves solubility of poorly soluble APIs.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Mannitol

Dosage Form : Granule / Pellet, Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Mannitol

Dosage Form : Granule / Pellet, Tablet

Category : Fillers, Diluents & Binders, Granulation, Solubilizers

Brand : MANNOGEM POWDER

Applications : Mannogem (mannitol powder) is an excellent excipient for use in wet granulation, lyophilization & improves solubility of poorly soluble APIs.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

02

Capital Farma

Spain

DCAT Week

Not Attending

Capital Farma, a leading European pharmaceutical company focusing on the development & distribution of niche APIs & Pharma Services.

Dosage Form : Tablet

Grade : Oral

Brand Name : Tartaric Acid

Application : Solubilizers

Excipient Details : Tartaric acid (Natural) is used to enhance the solubility of drugs with poor solubility, particularly in oral dosage forms.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Tartaric Acid

Dosage Form : Tablet

Grade : Oral

Capital Farma, a leading European pharmaceutical company focusing on the development & distribution of niche APIs & Pharma Services.

Ingredient(s) : Tartaric Acid

Dosage Form : Tablet

Category : Solubilizers

Brand : TARTARIC ACID

Applications : Tartaric acid (Natural) is used to enhance the solubility of drugs with poor solubility, particularly in oral dosage forms.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

03

SPI Pharma

U.S.A

DCAT Week

Attending

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Capsule, Granule / Pellet, Tablet

Grade : Oral

Brand Name : TAP®

Application : Solubilizers

Excipient Details : TAP® pellets are spherical cores made of tartaric acid used for solubility enhancement of drugs exhibiting poor solubility in alkali environments.

Pharmacopoeia Ref : NA

Technical Specs : Bulk density: 0.8-1.1 g/ml

Ingredient(s) : Tartaric Acid

Dosage Form : Capsule, Granule / Pellet, Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Tartaric Acid

Dosage Form : Capsule, Granule / Pellet, Tablet

Category : Solubilizers

Brand : TAP®

Applications : TAP® pellets are spherical cores made of tartaric acid used for solubility enhancement of drugs exhibiting poor solubility in alkali environments.

Pharmacopoeia Ref : NA

Technical Specs : Bulk density: 0.8-1.1 g/ml

Grade : Oral

04

BASF

KOLLIWAX GMS II

BioAsia

Not Confirmed

Looking for Solubilizers? Find Solubilizers Agents used in Topotecan Hydrochloride to address drug delivery challenges on PharmaCompass.

Topotecan Hydrochloride

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

17 API Suppliers

8 USDMF

1 EU WC

4 KDMF

3 NDC API

11 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

15 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

72 FDF Dossiers

22 FDA Orange Book

31 Europe

5 Canada

4 Australia

4 South Africa

6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - EQ 1MG BASE/ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INTRAVENOUS - EQ 3MG BASE/3ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INTRAVENOUS - EQ 4MG BASE/4ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INTRAVENOUS - EQ 4MG BASE/4ML (EQ 1MG BASE/ML)

INJECTABLE;INJECTION - EQ 4MG BASE/VIAL

CAPSULE;ORAL - EQ 0.25MG BASE

CAPSULE;ORAL - EQ 1MG BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

14 SPI Pharma

6 DKSH

1 Faran Shimi Pharmaceutical

1 Gangwal Healthcare

1 Pfanstiehl

1 Capital Farma

4 ACG Worldwide

1 Actylis

2 BASF

3 Gangwal Chemicals

1 Ingredion Pharma Solutions

6 Kerry

3 Lonza Capsugel

2 Microlex e.U

1 Pluviaendo

1 Qualicaps

5 Roquette

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

21 Fillers, Diluents & Binders

11 Chewable & Orodispersible Aids

11 Taste Masking

10 Direct Compression

9 Co-Processed Excipients

8 Empty Capsules

7 Disintegrants & Superdisintegrants

6 Coating Systems & Additives

5 Thickeners and Stabilizers

5 Parenteral

4 Solubilizers

3 Granulation

2 Film Formers & Plasticizers

2 Coloring Agents

1 Topical

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow

21 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

20 Finished Drug Prices

MARKET PLACE

4 APIs

SOLUTION;INTRAVENOUS - EQ 1MG BASE/ML (EQ 1MG BASE/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;INTRAVENOUS - EQ 3MG BASE/3ML (EQ 1MG BASE/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;INTRAVENOUS - EQ 4MG BASE/4ML (EQ 1MG BASE/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons